HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reverse Engineering Can Be Least Of Fragrance IP Worries

This article was originally published in The Rose Sheet

Executive Summary

Reverse-engineering a fragrance to uncover trade secrets at least takes time and resources, unlike instances where a former employee simply delivers them to a competitor. The EU's provisional trade-secret directive will promote improved protections against such conduct but will not affect laws of contract, so confidentiality agreements will remain important tools to guard against trade-secret misappropriation.

You may also be interested in...



P&G To Disclose Fragrance Ingredients Portfolio-Wide By 2020

NGOs are trumpeting P&G's fragrance disclosure announcement as a major victory for public health and a turning point for the entire consumer products industry. The initiative, which follows a similar move from Unilever in February, will provide visibility into fragrance formulae across more than 2,000 P&G products.

IFRA’s New Prez On Fragrance Transparency, The Science/Society ‘Interface’

Four months into her presidency, the International Fragrance Association’s new head discusses key issues and priorities, including ingredient disclosure in a sector that jealously guards its trade secrets.

J&J, Symrise Invest In Sunday II Sunday Hair Care For Active Women With Textured Hair

Johnson & Johnson Innovation led a $4.2m Series A financing announced on 25 March, which will help to build out Sunday II Sunday’s hair-care product offering and support in-store distribution in months to come.

Topics

UsernamePublicRestriction

Register

RS019890

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel